Competing against the big guys is always part of running a small business and is a particularly relevant issue for independent pharmacies that operate in the face of considerable pressures.
I want to tell you about a wall. One that stands between you and the value you create for your patients and the rest of the healthcare system. This wall may be preventing you from helping patients improve their health and preventing sustainable community-based pharmacy business models.
I hear it all. As the CEO of the National Community Pharmacists Association (NCPA), I have the awesome opportunity to speak in-person to over 5,000 pharmacy owners most years − the very people the organization exists to represent. During those conversations, owners usually have two issues on their minds: here and now issues (keeping the lights on per se) and where the profession is going in the future (seeing around the corner).
Pharmacy Benefit Manager (PBM) audits continue to plague pharmacies. There are more desk audits than ever before and plans are finding new ways to recoup payment on prescriptions.
(Spartanburg, SC – August 10, 2017) In a move that will greatly improve overall patient health, QS/1 has teamed with Script Management Partners (SMP) to offer pharmacies an electronic immunization reporting interface to state and local Immunization Information Systems (IIS). This interface is a turnkey solution to report all immunizations administered within each pharmacy to its respective IIS registry.
As of July 7, 2017, pharmacies in West Virginia are required to report Gabapentin as a Drug of Concern to the state’s Controlled Substance Monitoring Program (CSMP).
(Spartanburg, SC – August 4, 2017) QS/1 continues its effort to not only improve the health of our pharmacies’ patients, but also protect their sensitive financial information. With growing concerns of credit card data being compromised on merchant networks, QS/1 is proud to meet the stringent guidelines of the Qualified Integrators and Resellers (QIR) Program. This Payment Card Industry Data Security Standard (PCI DSS) qualification details the procedures for a secure installation and continued maintenance of payment application systems.
Beginning August 9, 2017, Schedule V controlled substances must be reported to the Arizona Controlled Substances Prescription Monitoring Program (PMP), in addition to already reported Schedule II, III and IV drugs.
(Spartanburg, SC – July 27, 2017) - The Board of Directors of J M Smith Corporation has confirmed Philip J. Ryan, III as Chief Financial Officer and appointed Kevin Welch to the role of Chief Technology Officer. Ryan will also assume the role of Treasurer following the retirement of James C. Wilson, Jr. on October 1, 2017. Wilson has been employed with the company since 1987, serving first as controller before being elected Treasurer and then being named CFO.
Effective Tuesday, August 15, 2017, the Colorado Prescription Drug Monitoring Program (CO PDMP) will change how prescription data submissions are reported by moving to Appriss® PMP AWARxE™.